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ABSTRACT 
Inflammation involves a sequence of events which can be categorized under three phases viz. acute transient phase, delayed sub-acute phase and 
chronic proliferate phase. Inflammatory mediators develop due to enhanced vascular permeability and leads to local edema. It is followed by the 
migration of leukocytes and phagocytes from blood to vascular tissues which is the second phase, in the third phase, tissue degradation is 
followed by fibrosis. There is a powerful link between chronic diseases and chronic inflammatory disorders. Chronic low-level inflammation 
contributes to the pathogenesis of these several diseases like Heart disease, Cancer, Chronic lower respiratory disease, Stroke, Alzheimer’s, 
Diabetes, and Nephritis. The harmful side effects of synthetic drugs are numerous and there stands up the need of herbal drugs which are cost 
effective and free from side-effects. Several traditional ayurvedic phytomedicines have been used in the treatment of inflammatory disorders like 
Ocimum sanctum, Hypericum peroratum, Boswellic serrata, Ficus racemosa etc. which act as natural anti-inflammatory agents that can help in 
reducing the complications associated with chronic diseases.  
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The word “inflammation”, derived from the latin word 
“inflammare”, (to set on fire), is a complex biological process 
which involve several chemical mediators which are induced 
by vascular tissue of the body, which when it comes in 
contact with several harmful stimuli like pollens, irritants, 
pathogens, and damaged cells. When human body is injured 
there occurs a series of chemical changes. Inflammation was 
prematurely considered as a single disease caused by 
disturbances of various fluids of the body. Nowadays, the 
modern concept of inflammation is a healthy process 
resulting from some disturbance or disease. 
 
Table 1: Cardinal signs of Inflammation 
Cardinal Signs of Inflammation 
Redness Heat Swelling Pain Loss of Function 
Caused by dilation 







flow to skin surface 
 
Caused by accumulation 




Direct injury of nerve fibers, 
pressure on hematoma on 








Inflammation is frequently associated with pain, and 
involves occurrences such as the increase of vascular 
permeability, membrane alteration and increase of 
membrane permeability. When the injury is in the form of 
stress cells in the body are damaged by micro-organisms, 
physical agents or chemical agents. Inflammation of tissue is 
due to response to stress or free radicals. The humans’ 
defensive response is characterized by redness, pain, heat 
and swelling and loss of function in the injured area. Loss of 
function depends on the site and extent of injury. 
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Inflammation is now recognized as an overwhelming burden 
to the healthcare status of human population and the 
underlying pathogenesis basis of a significant number of 
chronic diseases. Worldwide the annual mortality due to 
Chronic Inflammatory Diseases is expected to increase. By 
2030, it has been estimated that 171 million people will be 
affected by chronic inflammatory diseases in the United 
States1. There is a strong link between chronic inflammatory 
conditions and chronic diseases. Chronic inflammation 
damages the cells of the brain, heart, arterial walls, and other 
anatomic structures and this damage leads to various 
inflammatory chronic diseases. Chronic low-level 
inflammation contributes to the pathogenesis of these 
several diseases like Heart disease, Cancer, Chronic lower 
respiratory disease, Stroke, Alzheimer’s, Diabetes, and 
Nephritis (kidney inflammation).Inflammation produces 
complex biological changes of vascular tissues which are 
produced by harmful stimuli, such as pathogens, damaged 
cells, or irritants2. Inflammation is a protective attempt by 
the organism to remove the injurious stimuli and to initiate 
the healing process. Although infection is caused by a 
microorganism, inflammation is one of the responses of the 
organism to the pathogenic organism. However, 
inflammation is a stereotyped response, and therefore it is 
considered as a mechanism of innate immunity, as compared 
to adaptive immunity, which is specific for each pathogen3. 
Inflammation is part of a complex biological response to 
harmful stimuli. 
Inflammation has been variously defined Houck (1963) as a 
vital response of tissue injury. Inflammation is the tissue 
reaction to infection, irritation or foreign substance. It is a 
part of the host defense mechanisms that are known to be 
involved in the inflammatory reactions such as release of 
histamine, bradykinin & prostaglandins. The development of 
non-steroids in overcoming human sufferings caused by 
inflammation such as Rheumatoid arthritis has evoked much 
interest in the extensive search for new drugs with this 
property4. Inflammation is a major component of the damage 
caused by autoimmune diseases and is also a fundamental 
contributor to diseases such as cancer, diabetes and 
cardiovascular disease5. 
The inflammatory process can also be defined as a sequence 
of events that occurs in response to noxious stimuli, infection 
or trauma6. The events of inflammation that underline these 
manifestations are induced and regulated by a large number 
of chemical mediators, including kinins, eicosanoids, 
complement proteins, histamine and monokines. Efficacy of 
anti-inflammatory agents in inflammatory states is indicated 
by their ability to inhibit the increase in the number of 
fibroblast during granular tissue formation7. 
Causes of inflammation: 
The numerous causes of inflammation may be classified as  
 Microbes e.g. bacteria viruses, protozoa, fungi 
 Physical agents e.g. heat cold, mechanical injury ultra 
violet and ionizing radiation 
 Chemical agents organic e.g. microbial toxins and 
organic poisons such as weed killers 




Figure 1: Causes of Inflammation    
Mechanism of Inflammation: 
Mechanism of inflammation is due to result of 
proinflammatory cytokines and chemokine release in 
response to injury or infection, mast cells in connective 
tissue as well as basophils, neutrophils and platelets leaving 
the blood from injured capillaries, release or stimulates the 
synthesis of vasodilators such as histamine, leukotrienes, 
bradykinins and prostaglandins. Certain products of 
complement pathways (C5a and C3a) can also trigger mast 
cells to release their vasodilators. 
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Figure 2: Diagrammatic Representation of the Prostaglandin Pathway 
 
Diseases Associated with Chronic Inflammation: 
Inflammation produces reactive oxygen species and reactive 
nitrogen species, which causes oxidative damage and further 
lead to chronic diseases8.  These include heart disease, 
cancer, chronic lower respiratory diseases, stroke, 
Alzheimer’s disease, diabetes, and nephritis. 
 
Figure 2: Diseases associated with Chronic Inflammation 
 Cardiovascular diseases (CVD)  
Inflammation is a fundamental part of atherosclerosis 
(oxidized low-density lipoprotein cholesterol evokes the 
inflammatory response). Circulating inflammatory cytokines 
are predictive of peripheral arterial diseases, heart failure, 
atrial fibrillation, stroke, and coronary heart disease.9C-
Reactive Protein, an acute-phase protein are produced by the 
liver during bacterial infections and inflammation which was 
found to be a common marker for detecting cardiovascular 
and atherosclerotic diseases.10 
 Cancer 
Several studies reported the prominent links between 
chronic low-level inflammation and several types of cancers, 
including lymphoma, prostate, ovarian, pancreatic, colorectal 
and lung11. There are several mechanisms by which 
inflammatory mediators may contribute to pathogenesis of 
carcinogenesis, including alterations in gene expression, 
DNA mutation, epigenetic alterations, promotion of tumor 
vascularization, and the expression of pro-inflammatory 
cytokines that have roles in cancer cell proliferation.12 
Various pro-inflammatory mediators have been found to be 
elevated in several cancers. The pro-inflammatory 
biomarker STAT3 was found to be activated in 82% of 
patients with late-stage prostate cancer.13,14,15 Another 
inflammatory transcription factor, NF-κB, was found in 60% 
of colorectal cancer patients. Also, the overproduction of 
cytokines has shown to be associated with cancer-related 
fatigue.16 
 Diabetes 
Inflammation is linked to diabetes and stands up insulin 
resistance. This fact has generated a growing interest in 
alternative anti-inflammatory therapies to slow down 
diabetes and complications associated with it. Nowadays, 
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diabetes is considered an inflammatory disease. The 
infiltration of macrophages into fat tissues and their 
subsequent release of pro-inflammatory cytokines into 
circulation occur at a greater rate in type II diabetics than in 
non-diabetics.17,18 Pro-inflammatory cytokines clearly 
decrease insulin sensitivity and increase diabetic 
complications like nephropathy etc.19 
 Polycystic Ovarian Syndrome 
Chronic low grade inflammation has emerged as a key 
contributor to the pathogenesis of Polycystic ovarian 
syndrome. The proinflammatory cytokine tumor necrosis 
factor α is a known mediator of insulin resistance. Glucose 
stimulated TNF α release from MNC along with molecular 
markers of inflammation are associated with insulin 
resistance in PCOS. Increased abdominal adiposity is 
prevalent across all weight classes in PCOS and this 
inflammed tissue contributes to the inflammatory load in the 
disorder. According to 2009 study in the journal metabolism, 
levels of inflammatory markers in the blood are increased 
not only in overweight or obese women with PCOS but also 
in normal weight women thus supporting the fact that 
inflammation directly plays key role in PCOS. 
 Age-related macular degeneration (AMD).  
A study report of 11 population-based studies estimating 
over 41,000 patients demonstrated a clear association 
between elevated serum C-Reactive Protein levels (> 3 
mg/L) and the incidence of late onset Age-related macular 
degeneration.20The risk of Age related macular degeneration 
in these high-C-Reactive Protein patients was increased over 
2-fold compared with patients with CRP levels < 1 mg /L. 
 Osteoporosis. 
The Inflammatory cytokines like TNF-α, IL-1β, IL-6 are 
involved in normal bone metabolism. Osteoclasts, the cells 
that break down (resorb) bone tissue, are a type of 
macrophage and can be stimulated by pro-inflammatory 
factors. Systemic elevations in pro-inflammatory cytokines 
push bone metabolism towards resorption, and have been 
observed to induce bone loss in persons with periodontal 
diseases, pancreatitis, inflammatory bowel diseases, and 
rheumatoid arthritis.21 An increase in the levels of 
inflammatory cytokines is also a mechanism by which 
menopause stimulates bone loss. 
 Cognitive decline 
Several observational studies reported linked chronic low-
level inflammation in older adults to cognitive decline and 
dementia, including vascular dementia and Alzheimer’s 
disease.22One study found that people with the highest CRP 
and IL-6 levels (> 2.4 pg/mL) had a ~30-40% increased risk 
of cognitive decline compared to those with the lowest levels 
(< 1.4 pg/mL).23 Inflammatory markers can be elevated 
before the onset of cognitive dysfunction, indicating their 
potential relevance as a prognostic tool in high-risk 
individuals 
 Multiple sclerosis 
An autoimmune disease is caused by chronic inflammation in 
the central nervous system disease. Activated NF-κB is found 
in patients with multiple sclerosis.24 High levels of other 
cytokines such as IL-1α, IL-2, IL-4, IL-6, IL-10, IFN-γ, TGF-β1, 
TGF-β2, and TNF-α have also been found in frozen sections 
of central nervous system tissue from multiple sclerosis 
patients.25 
 Vasculitis  
Vasculitis is a group of diseases in which inflammation of the 
blood vessels is the distinctive feature. Such inflammation 
can cause narrowing and weakness of the vessel linings and 
in some instances a tendency to form small clots affects the 
vessels that can result in damage to the tissues or organs 
being supplied by those blood vessels, including the kidney, 
lung, skin, nerves, or even the brain. 
 Inflammatory Bowel Disease 
Inflammatory bowel diseases are a group of inflammatory 
disorders of the colon and small intestine comprising in 
Crohn’s disease (CD) and ulcerative colitis (UC). 
Inflammatory Bowel Diseases causes inflammation 
anywhere along the lining of digestive tract and often 
spreads deep into affected tissues. A number of cytokines 
/chemokines and their receptors have shown to be 
upregulated in patients with Inflammatory Bowel Diseases. 
For example, the overproduction of various cytokines such 
as IL-2, IL-12, IL-18, IFN-γ, and TNF-α has been well 
registered in patients with Crohn’s Diseases.26,27 
 Ankylosing spondylitis 
It is a chronic inflammatory disorder of unknown origin that 
primarily affects the spine, sternum, and large joints in the 
body. The most distinctive feature of this condition is a 
siginificant or complete loss of flexibility in the body and 
spine. People with this disorder experience lower back pain, 
morning stiffness, and limited motion. These symptoms are 
commonly improved after exercise and get worsened after 
sleep or prolonged rest. 
 Gout 
Gout  is a form of inflammatory arthritis that results from an 
excess of uric acid which is a chemical that is released as the 
body breaks down certain substances in food called purines 
in the blood of human body. In people with gout, uric acid 
crystallizes in the joints causing painful attacks in the 
affected body part – often, initially, a big toe. 
 Myositis 
The myositis “muscle inflammation” is caused by white 
blood cells called lymphocytes, which are normally supposed 
to protect the body’s immune system. In inflammatory 
myopathies such as myositis, lymphocytes infiltrate the 
healthy muscle fibers that are destroyed and affect the 
functionality of muscle tissue leading to fatigue and 
immobility. 
 Others 
Elevated inflammatory cytokines in the circulation are 
associated with several other Chronic conditions, like 
Crohn’s disease, pancreatitis.28,29,30,31,32 Inflammation is also 
a cause of autoimmune diseases such as rheumatoid 
arthritis, in which excess levels of cytokines such as TNF-α, 
IL-6, IL-1β, and IL-8 are often found.33 
Herbs as alternative source of the Treatment of 
Inflammatory disorders: 
Medicinal plants provide an important source of new 
chemical substances with potential therapeutic effects. These 
have been used in traditional medicine for the treatment of 
several diseases.34 The number of studies investigating oral 
herbal anti-inflammatory drugs in the treatment of 
osteoarthritis (OA) and low back pain is steadily increasing 
and an updated Cochrane Systematic Review on ‘Herbal 
Therapy for Osteoarthritis’ is expected soon35. Whereas in 
Germany, preparations from devil’s claw, willow bark and 
nettle herb are widely used as Osteoarthirits 
pytomedicines.36Preparations from ginger37,38,39 or salai 
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guggal40 or the gamma linolenic acid (GLA) containing seed 
oils from evening primrose, borage or blackcurrant.41,42,43are 
less popular for the treatment of osteoarthritic pain in 
Europe. 
NSAIDs are among the most widely used drugs worldwide. 
They are prescribed for orthopaedic conditions such as 
osteoarthritis, soft-tissue injuries and fractures etc.45 NSAIDs 
are one of the best classes of drug to prevent and treat 
postoperative pain.46 The use of NSAIDs is associated with 
many side effects, but their harmful effects on the 
gastrointestinal tract, the kidney and the cardiovascular 
system are considered as major issues with the use of these 
drugs47 Inflammatory diseases including different types of 
rheumatic diseases are very common throughout the world. 
Several indigenous drugs have been described in Ayurveda 
for the management of inflammatory diseases48 
Combinations of pharmacologically active principles in 
different plant families and species often exhibit remarkable 
potency and tolerance, particularly in the long term 
treatment of chronic disorders, like rheumatic diseases49 The 
greatest disadvantage in presently available potent synthetic 
drugs lies in their toxicity and reappearance of symptoms 
after discontinuation. Therefore, the screening and 
development of drugs for their anti-inflammatory activity is 
the need of hour and there are many efforts for finding anti-
inflammatory drugs from indigenous medicinal plants50. 
Lipopolyssacharide (LPS) - activated macrophages are 
usually used for evaluating the anti-inflammatory effects of 
various materials. Lipopolysaccharide is a principle 
component of the outer membrane of Gram-negative 
bacteria which is an endotoxin that induces septic shock 
syndrome and stimulates the production of inflammatory 
mediators such as nitric oxide (NO), tumor necrosis factor-a 
(TNF-α), interleukins, prostanoids, and leukotrienes51,52,53 It 
is interesting to mention that more than 70% of anti-
inflammatory drugs are synthetic and among all of these 
plant derived prototype asprin is considered as one of the 
most effective analgesic and anti-inflammatory agent and 
commonly used in modern medicine. Several terrestrial 
plants have been used in traditional ayurvedic medicine for 
treatment and management of distinct anti-inflammatory 
disorders and wound healing. Such as Boswellic serrata 
(burseraceae), curcuma long (zingiberaceae), Ficus racemosa 
(moraceae) andocimum sanctum (labiatae) and hypericum 
perforatum (clusiaceae) and their active principle 
constituents like boswellic acid, curcumin, racemosic acid 
and flavanoid and hyperforin have shown to be responsible 
for pharmacological action. The anti-inflammatory action of 
these compounds have been associated with the inhibition of 
prostaglandin/or leukotrienes synthesis via interfering with 
COX and 5-LOX enzyme or inhibiting their expression. Unlike 
modern allopathic drugs which are single active components 
that target one specific pathway, herbal medicines work in a 
way that depends on an orchestral approach. A plant 
contains a multitude of different molecules that act 
synergistically on targeted elements of the complex cellular 
pathway. Medicinal plants have been source of wide variety 
of biologically active compounds for many centuries and 
used extensively as crude material or as pure compounds for 
treating various disease conditions.  
Conclusion: 
There is powerful link between chronic diseases and 
inflammation. Inflammatatory biomarkers play an important 
role in the elevation of chronic diseases which is a critical 
issue and needs to be taken care of. Focusing on reducing 
inflammatory stress can reduce the complications of Chronic 
Diseases. Phytomedicines play an important role in curing 
these diseases, as they contain important phytoconstituents 
which have been proved since time immemorial beneficial in 
treating chronic diseases which are cost effective and free 
from harmful side effects. 
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